This study, which is being conducted as part of a Quality Improvement (QI) Initiative at Columbia University Irving Medical Center, will test whether deliverin…

Depression and CVD

~Estimated

~$10 – $6,250

Columbia UniversityNCT07390331

Phase 2

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics (PopPK) Profile of ABP-745 in Patients With Atherosclerosis

This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 i…

Atherosclerosis Cardiovascular DiseaseASCVDASCVD Management

~Estimated

~$10 – $8,750

Atom Therapeutics Co., LtdNCT07303777

← PreviousPage 3 of 3Next →